Company
Tessellate Bio
- Biotech
- Locations:
- Naarden, Netherlands · Stevenage, United Kingdom
Description
Tessellate Bio discovers and develops precision oncology small-molecule medicines based on novel synthetic lethality interactions, incorporating biomarker discovery and companion diagnostics for targeted cancer treatments.
Tessellate Bio is located in the Netherlands ecosystem.
Related
RS ResearchRS Research develops targeted oncology therapies and smart nanomedicines using the Sagitta® polymer-drug conjugate platform for targeted…
ElektaElekta develops radiotherapy, brachytherapy and imaging systems for precision radiation medicine used by hospitals and cancer centres to…
NeoPhoreNeoPhore develops small-molecule cancer therapeutics that briefly inhibit DNA mismatch repair, shifting MMR-proficient tumors toward an…
BioInvent InternationalBioInvent International discovers and develops antibody therapeutics for cancer treatment, using immunology, cancer biology, antibody…
Dynamic BiosensorsDynamic Biosensors develops switchSENSE® and single-cell Interaction Cytometry (scIC) technologies that characterize molecular interactions…
OncolinesOncolines provides precision medicine services in oncology and cancer immunotherapy, offering cell‑based assays, profiling platforms,…
NETRIS PharmaNETRIS Pharma develops therapeutics that target Netrin-1 to overcome resistance to oncology treatments, producing monoclonal antibodies…
BIMINI BiotechBIMINI Biotech develops first-in-class small-molecule therapeutics targeting the Wiskott–Aldrich Syndrome protein for oncology and…
EndoVia TherapeuticsEndoVia Therapeutics builds a precision oncology platform that combines tumor profiling and AI-driven digital twin models to predict,…